Back to HSCSWView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Respiratory Distress Syndrome in Premature Infant
View Full LandscapeDrug Information
Target Indication
Respiratory Distress Syndrome in Premature Infant
Clinical Trial
NCT01473264Last updated: 9/18/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Ferric Derisomaltose 1000 Mg in 100 mL INTRAVENOUS SOLUTION [Monoferric]Phase 3
Iron-deficiency
Sacubitril-Valsartan 49 Mg-51 Mg Oral TabletPhase 3
Obesity
Mono-Therapy with SildenafilPhase 3
Pediatric Pulmonary Hypertension
Convalescent PlasmaPhase 3
Covid19
FosinoprilPhase 3
Microalbuminuria
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts